Research location
Jilin City
China
Advertisement
Research activity in Jilin City
ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 24 trials and 25 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Jilin City
24 linked trials · page 1 of 1SKB264 in Combination With SKB118 for Non-Small Cell Lung CancerNCT07697586 · 2026-08-07 · 1 site observation
RECRUITING
Digital Remote Management Versus Usual Care for Optimization of Guideline-directed Medical Therapy in Patients With Heart Failure and Reduced Ejection Fraction: a Multicentre, Randomised, Controlled Trial (DigiCare-HFrEF)NCT07352891 · 2026-02-26 · 1 site observation
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation
RECRUITING
Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLCNCT06496048 · 2024-09-14 · 1 site observation
RECRUITING
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid TumorsNCT04930432 · 2021-09-24 · 1 site observation
RECRUITING
Covered vs Bare Metal Stents for Atherosclerotic Renal Artery StenosisNCT07566065 · 2026-04-30 · 1 site observation
NOT_YET_RECRUITING
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBCNCT07376629 · 2025-08-14 · 1 site observation
ENROLLING_BY_INVITATION
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients With DiabetesNCT06331923 · 2024-04-12 · 1 site observation
COMPLETED
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)NCT05668988 · 2022-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male SubjectsNCT05576454 · 2022-09-20 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive DisorderNCT06796868 · 2022-07-07 · 1 site observation
COMPLETED
Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid ArthritisNCT05957107 · 2022-05-26 · 1 site observation
COMPLETED
Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related EpilepsyNCT05604170 · 2022-05-16 · 1 site observation
TERMINATED
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)NCT04998032 · 2021-10-12 · 1 site observation
COMPLETED
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)NCT05171816 · 2021-06-24 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLCNCT04672369 · 2021-06-06 · 1 site observation
COMPLETED
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese PatientsNCT04560452 · 2021-03-15 · 1 site observation
COMPLETED
A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung CancerNCT04672356 · 2021-01-25 · 1 site observation
COMPLETED
IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung CancerNCT04434482 · 2020-08-07 · 1 site observation
COMPLETED
A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)NCT03660059 · 2018-09-27 · 1 site observation
COMPLETED
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer PatientsNCT05023746 · 2018-08-30 · 1 site observation
COMPLETED
Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma.NCT03453112 · 2017-10-09 · 1 site observation
COMPLETED
T790M Mutation Positive 2nd Line STandard of cAre RegistryNCT02368990 · 2015-06-01 · 1 site observation
WITHDRAWN
An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044NCT02319642 · 2014-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.